Авторы

  • Мухиддинова М.С., Махкамова Д.К.

Ключевые слова:

васкулит зрительного нерва; оптическая когерентная томография; ОКТ-ангиография; компьютерная периметрия; эндотелин-1; бозентан; антикоагулянтная терапия

Библиографические ссылки

1. Hayreh SS. Optic disc vasculitis. Br J Ophthalmol. 1972;56(9):652-670.

2. Petzold A, Fraser CL, Abegg M, Biousse V, Newman NJ, Vignal-Clermont C, et al. Diagnosis and classification of optic neuritis. Lancet Neurol. 2022; 21(12):1120-1134.

3. Insausti-García A, Reche-Sainz JA, Ruiz-Arranz C. Papillophlebitis in a COVID-19 patient: inflammation and hypercoagulable state. Eur J Ophthalmol. 2022;32(1):NP168-NP172.

4. Witkin AJ, Hahn P, Murray TG, Berrocal AM, Wheatley HM, Prenner JL, et al. Occlusive retinal vasculitis following intravitreal brolucizumab. J Vitreoretin Dis. 2020;4(4):269-279.

5. El-Gendy RS, El-Hamid ASA, Galhom AEA. Diagnostic dilemma of papilledema and pseudopapilledema. Int Ophthalmol. 2024;44(1):272.

6. Yusupov A.F, Karimova M.Kh, Makhkamova D.K, Mukhiddinova M.S. Optic nerve vasculitis: literature review. Ophthalmology Eastern Europe. 2025;15(2).

7. Sibony P, Kupersmith MJ, Rohlf FJ. OCT neuro-toolbox for the diagnosis and management of papilledema, optic disc edema, and pseudopapilledema. J Neuroophthalmol. 2021;41(1):74-85.

8. Rebolleda G, Díez-Álvarez L, Casado A, Muñoz-Negrete FJ. OCT: new perspectives in neuroophthalmology. Saudi J Ophthalmol. 2015;29(1):9-25.

9. Fard MA, Suwan Y, Moghimi S, Geyman LS, Chui TYP, Rosen RB, et al. Pattern of peripapillary capillary dropout in ischemic optic neuropathy vs optic neuritis using OCT angiography. PLoS One. 2018; 13(4): e0195825. doi: 10.1371/journal. pone.019 5825.

10. Cellini M, Strobbe E, Gizzi C, Balducci N, Campos EC. Endothelin-1 plasma levels and vascular endothelial dysfunction in primary open angle glaucoma. Life Sci. 2012;91(13-14):699-702.

11. Bhatt DL, Bhatt UD, Barsness GW. Endothelin-1 role in human eye: a review. J Ophthalmol. 2011;2011:989048. doi: 10.1155/2011/989048.

12. Masaki T. Endothelin and endothelial dysfunction. J Cardiovasc Pharmacol. 2022;44(Suppl 1): S4-S7.

13. Schmetterer L, Polak K, Wolzt M, Findl O, Petternel V, Graselli U, et al. Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects. Invest Ophthalmol Vis Sci. 2008;49(9):3966-3971. doi: 10.1167/ iovs.07-1581.

14. Vignal-Clermont C, Audo I, Sahel JA, Paques M, Mohand-Said S, Guillaumie L, et al. Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION - a multicentre randomised controlled trial protocol. Trials. 2022;23(1):889. doi: 10.1186/s13063-022-06839-7.

15. Simó R, Bhosale P, Wilsey M, Bhatt U. Topical administration of bosentan prevents retinal neurodegeneration in experimental diabetes. Front Ophthalmol. 2018;2018:1185755.

16. Howell GR, Soto I, Ryan M, Graham LC, Smith RS, John SW. Deficiency of complement component 5 ameliorates glaucoma in DBA/2J mice. J Neuroinflammation. 2013;10:76.

17. Bhosale P, Wilsey M. Effects of an endothelin receptor antagonist on a model of hypertensive retinopathy. Ophthalmic Res. 2009;43(1):53-61. doi: 10.1159/000197707.

18. Steigerwalt RD Jr, Cesarone MR, Belcaro G, Pascarella A, De Angelis M, Bacci S. Retinal and orbital venous occlusions treated with enoxaparin. Int J Angiol. 2008;17(4):193-196.

19. Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: clinical characteristics in diabetic patients versus nondiabetic patients. Ophthalmology. 2008;115(10):1818-1825.

20. Dragoni F, Kaarniranta K. Individual benefits of enoxaparin treatment in branch vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2018;256 (5):1031-1033.

21. Fekrat S, Kim GN, Talman LS, Meyerle C, Scott IU, Ip MS, et al. Central retinal vein occlusion: the effect of antiplatelet and anticoagulant agents. Ophthalmol Retina. 2022;6(4):342-350.

22. Lee J, Kim BJ, Kim US. Efficacy and safety of non-vitamin K-antagonist oral anticoagulants for retinal vascular diseases in patients with atrial fibrillation: Korean cohort study. BMJ Open Ophthalmol. 2020;5(1):e000353. doi: 10.1136/bmjophth-2019-000353.

23. Flammer J, Konieczka K, Bruno RM, Virdis A, Flammer AJ, Taddei S. The eye and the heart. Eur Heart J. 2013;34(17):1270-1278.

24. Behbehani R. Clinical approach to optic neuropathies. Clin Ophthalmol. 2007;1(3):233-246.

25. Samuel MA, Equi RA, Chang TS, Mieler W, Jampol LM, Hay G, et al. Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system. Ophthalmology. 2007;114(8):1526-1529.

26. Toosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol. 2014;13(1):83-99.

27. Fraser JA, Bruce BB, Rucker J, Wright D, Biousse V, Newman NJ, et al. Risk factors for idiopathic intracranial hypertension in men: a case-control study. J Neurol Sci. 2010;290(1-2):86-89.

28. Hayreh SS. Anterior ischemic optic neuropathy. Clin Neurosci. 1997;4(5):251-263.

29. Leavitt JA, Larson TA, Hodge DO, Gullerud RE. The incidence of central retinal artery occlusion in Olmsted County, Minnesota. Am J Ophthalmol. 2011;152(5):820-823.

30. Winterkorn JM, Mack PB, Stricker EJ. Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med. 1993; 329(24):1753-1755.